114 related articles for article (PubMed ID: 37609317)
1. Mechanisms of Pathogenicity of Hypertrophic Cardiomyopathy-Associated Troponin T (TNNT2) Variant R278C
Shafaattalab S; Li AY; Jayousi F; Maaref Y; Dababneh S; Hamledari H; Baygi DH; Barszczewski T; Ruprai B; Jannati S; Nagalingam R; Cool AM; Langa P; Chiao M; Roston T; Solaro RJ; Sanatani S; Toepfer C; Lindert S; Lange P; Tibbits GF
bioRxiv; 2023 Aug; ():. PubMed ID: 37609317
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Arrhythmogenicity of Hypertrophic Cardiomyopathy-Associated Troponin T (
Shafaattalab S; Li AY; Gunawan MG; Kim B; Jayousi F; Maaref Y; Song Z; Weiss JN; Solaro RJ; Qu Z; Tibbits GF
Front Cell Dev Biol; 2021; 9():787581. PubMed ID: 34977031
[TBL] [Abstract][Full Text] [Related]
3. Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytes.
Schuldt M; Johnston JR; He H; Huurman R; Pei J; Harakalova M; Poggesi C; Michels M; Kuster DWD; Pinto JR; van der Velden J
J Mol Cell Cardiol; 2021 Jan; 150():77-90. PubMed ID: 33148509
[TBL] [Abstract][Full Text] [Related]
4. Development of a Cardiac Sarcomere Functional Genomics Platform to Enable Scalable Interrogation of Human
Pettinato AM; Ladha FA; Mellert DJ; Legere N; Cohn R; Romano R; Thakar K; Chen YS; Hinson JT
Circulation; 2020 Dec; 142(23):2262-2275. PubMed ID: 33025817
[TBL] [Abstract][Full Text] [Related]
5. Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes.
Wang L; Kim K; Parikh S; Cadar AG; Bersell KR; He H; Pinto JR; Kryshtal DO; Knollmann BC
J Mol Cell Cardiol; 2018 Jan; 114():320-327. PubMed ID: 29217433
[TBL] [Abstract][Full Text] [Related]
6. F110I and R278C troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in transgenic mice and reconstituted human cardiac fibers.
Hernandez OM; Szczesna-Cordary D; Knollmann BC; Miller T; Bell M; Zhao J; Sirenko SG; Diaz Z; Guzman G; Xu Y; Wang Y; Kerrick WG; Potter JD
J Biol Chem; 2005 Nov; 280(44):37183-94. PubMed ID: 16115869
[TBL] [Abstract][Full Text] [Related]
7. Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for
Kondo T; Higo S; Shiba M; Kohama Y; Kameda S; Tabata T; Inoue H; Okuno S; Ogawa S; Nakamura S; Takeda M; Ito E; Li J; Liu L; Kuramoto Y; Lee JK; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
Circ Genom Precis Med; 2022 Oct; 15(5):e003522. PubMed ID: 35861968
[TBL] [Abstract][Full Text] [Related]
8. Low expression of the K280N
Sequeira V; Wang L; Wijnker PJM; Kim K; Pinto JR; Dos Remedios C; Redwood C; Knollmann BC; van der Velden J
J Mol Cell Cardiol Plus; 2022 Sep; 1():100007. PubMed ID: 37159677
[TBL] [Abstract][Full Text] [Related]
9. Genetic Studies of Hypertrophic Cardiomyopathy in Singaporeans Identify Variants in
Pua CJ; Tham N; Chin CWL; Walsh R; Khor CC; Toepfer CN; Repetti GG; Garfinkel AC; Ewoldt JF; Cloonan P; Chen CS; Lim SQ; Cai J; Loo LY; Kong SC; Chiang CWK; Whiffin N; de Marvao A; Lio PM; Hii AA; Yang CX; Le TT; Bylstra Y; Lim WK; Teo JX; Padilha K; Silva GV; Pan B; Govind R; Buchan RJ; Barton PJR; Tan P; Foo R; Yip JWL; Wong RCC; Chan WX; Pereira AC; Tang HC; Jamuar SS; Ware JS; Seidman JG; Seidman CE; Cook SA
Circ Genom Precis Med; 2020 Oct; 13(5):424-434. PubMed ID: 32815737
[TBL] [Abstract][Full Text] [Related]
10. Delineation of Molecular Pathways Involved in Cardiomyopathies Caused by Troponin T Mutations.
Gilda JE; Lai X; Witzmann FA; Gomes AV
Mol Cell Proteomics; 2016 Jun; 15(6):1962-81. PubMed ID: 27022107
[TBL] [Abstract][Full Text] [Related]
11. Establishing a new human hypertrophic cardiomyopathy-specific model using human embryonic stem cells.
Cai H; Li B; Bai A; Huang J; Zhan Y; Sun N; Liang Q; Xu C
Exp Cell Res; 2020 Feb; 387(1):111736. PubMed ID: 31759053
[TBL] [Abstract][Full Text] [Related]
12. Hypertrophic cardiomyopathy: low frequency of mutations in the beta-myosin heavy chain (MYH7) and cardiac troponin T (TNNT2) genes among Spanish patients.
García-Castro M; Reguero JR; Batalla A; Díaz-Molina B; González P; Alvarez V; Cortina A; Cubero GI; Coto E
Clin Chem; 2003 Aug; 49(8):1279-85. PubMed ID: 12881443
[TBL] [Abstract][Full Text] [Related]
13. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.
Mori AA; Castro LR; Bortolin RH; Bastos GM; Oliveira VF; Ferreira GM; Hirata TDC; Fajardo CM; Sampaio MF; Moreira DAR; Pachón-Mateos JC; Correia EB; Sousa AGMR; Brión M; Carracedo A; Hirata RDC; Hirata MH
Forensic Sci Int Genet; 2021 May; 52():102478. PubMed ID: 33588347
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts--role of myofilament Ca2+ sensitivity increase.
Sirenko SG; Potter JD; Knollmann BC
J Physiol; 2006 Aug; 575(Pt 1):201-13. PubMed ID: 16777946
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of cardiomyopathy-associated variants in troponin genes identifies loci and intragenic hot spots that are associated with worse clinical outcomes.
Tadros HJ; Life CS; Garcia G; Pirozzi E; Jones EG; Datta S; Parvatiyar MS; Chase PB; Allen HD; Kim JJ; Pinto JR; Landstrom AP
J Mol Cell Cardiol; 2020 May; 142():118-125. PubMed ID: 32278834
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
[TBL] [Abstract][Full Text] [Related]
17. Tale of two hearts: a TNNT2 hypertrophic cardiomyopathy case report.
Pham JH; Giudicessi JR; Tweet MS; Boucher L; Newman DB; Geske JB
Front Cardiovasc Med; 2023; 10():1167256. PubMed ID: 37180798
[TBL] [Abstract][Full Text] [Related]
18. Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation.
Guo G; Wang L; Li X; Fu W; Cao J; Zhang J; Liu Y; Liu M; Wang M; Zhao G; Zhao X; Zhou Y; Niu S; Liu G; Zhang Y; Dong J; Tao H; Zhao X
Cell Calcium; 2024 Jan; 117():102822. PubMed ID: 38101154
[TBL] [Abstract][Full Text] [Related]
19. Hypertrophic cardiomyopathy mutation in cardiac troponin T (R95H) attenuates length-dependent activation in guinea pig cardiac muscle fibers.
Mickelson AV; Chandra M
Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1180-H1189. PubMed ID: 28842439
[TBL] [Abstract][Full Text] [Related]
20. Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy.
Szczesna D; Zhang R; Zhao J; Jones M; Guzman G; Potter JD
J Biol Chem; 2000 Jan; 275(1):624-30. PubMed ID: 10617660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
